We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNKD icon
1251
MannKind Corp
MNKD
$1.3B
$86.5K ﹤0.01%
16,572
+927
+6% +$4.21K
CLVT icon
1252
Clarivate
CLVT
$1.3B
$84.4K ﹤0.01%
14,830
-1,919
-11% -$12.2K
RC
1253
Ready Capital
RC
$304M
$84K ﹤0.01%
+10,274
New +$87.6K
LCID icon
1254
Lucid Motors
LCID
$1.99B
$83.4K ﹤0.01%
3,194
+549
+21% +$14.7K
BKD icon
1255
Brookdale Senior Living
BKD
$2.89B
$83K ﹤0.01%
12,159
+799
+7% +$5.4K
COMP icon
1256
Compass
COMP
$8.61B
$82.6K ﹤0.01%
22,948
+6,055
+36% +$22.2K
BCRX icon
1257
BioCryst Pharmaceuticals
BCRX
$2.52B
$80.2K ﹤0.01%
12,980
+1,505
+13% +$8.3K
INFN
1258
DELISTED
Infinera Corporation Common Stock
INFN
$76.7K ﹤0.01%
12,601
+647
+5% +$3.42K
UWMC icon
1259
UWM Holdings
UWMC
$2.47B
$76.5K ﹤0.01%
+11,032
New +$75.8K
PTON icon
1260
Peloton Interactive
PTON
$2.36B
$75.5K ﹤0.01%
22,345
-24,160
-52% -$86.5K
SIRI icon
1261
SiriusXM
SIRI
$9.64B
$75.2K ﹤0.01%
2,658
-3,676
-58% -$110K
MTTR
1262
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$74.7K ﹤0.01%
16,703
+639
+4% +$2.42K
SABR icon
1263
Sabre
SABR
$868M
$73.6K ﹤0.01%
27,554
+3,689
+15% +$10.3K
OPEN icon
1264
Opendoor
OPEN
$3.28B
$71.8K ﹤0.01%
40,297
+4,984
+14% +$10.7K
SOUN icon
1265
SoundHound AI
SOUN
$3.2B
$71.3K ﹤0.01%
+18,054
New +$83.7K
LUMN icon
1266
Lumen
LUMN
$6.33B
$70.9K ﹤0.01%
64,444
+2,487
+4% +$3.15K
SHLS icon
1267
Shoals Technologies Group
SHLS
$1.25B
$67.3K ﹤0.01%
10,786
+381
+4% +$3.04K
WULF icon
1268
TeraWulf
WULF
$8.02B
$65.5K ﹤0.01%
+14,712
New +$39.7K
AMRX icon
1269
Amneal Pharmaceuticals
AMRX
$6.3B
$64.9K ﹤0.01%
+10,214
New +$64.8K
INDI icon
1270
indie Semiconductor
INDI
$851M
$63.2K ﹤0.01%
+10,237
New +$65.1K
UUUU icon
1271
Energy Fuels
UUUU
$3.96B
$61.3K ﹤0.01%
+10,121
New +$61.8K
QS icon
1272
QuantumScape Corp
QS
$3.63B
$59.1K ﹤0.01%
12,008
-42
-0.3% -$234
SSRM icon
1273
SSR Mining
SSRM
$7.97B
$58.2K ﹤0.01%
+12,909
New +$66.2K
PGRE
1274
DELISTED
Paramount Group
PGRE
$54.6K ﹤0.01%
11,794
+731
+7% +$3.39K
NG icon
1275
NovaGold Resources
NG
$4.04B
$53.5K ﹤0.01%
15,471
+1,027
+7% +$3.41K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.